Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Ikuo Nomura"'
Autor:
Taro Kishi, Maika Nishida, Michinori Koebis, Takehiro Taninaga, Kenzo Muramoto, Naoki Kubota, Margaret Moline, Kenji Sakuma, Makoto Okuya, Ikuo Nomura, Nakao Iwata
Publikováno v:
Neuropsychopharmacology Reports, Vol 41, Iss 4, Pp 450-458 (2021)
Abstract Most conventional insomnia medications are gamma‐aminobutylic acid receptor agonists. However, physical dependence is a concern and one of the major limiting factors for long‐term treatment. The dual orexin receptor antagonists, suvorexa
Externí odkaz:
https://doaj.org/article/e1c3cd06cd9f45a8a585f4644d879cd0
Autor:
Taro Kishi, Kenji Sakuma, Makoto Okuya, Kohei Ninomiya, Kazuto Oya, Momoko Kubo, Yuki Matsui, Ikuo Nomura, Yuji Okuyama, Shinji Matsunaga, Nakao Iwata
Publikováno v:
Neuropsychopharmacology Reports, Vol 39, Iss 3, Pp 252-255 (2019)
Abstract Aim There have been no previous reports on the efficacy and safety of suvorexant for insomnia in people with psychiatric disorders. Methods This one‐week, prospective, single‐arm, clinical trial of fixed dose of suvorexant (20 mg if ages
Externí odkaz:
https://doaj.org/article/a0c6d2d8d32840e0894e9fb799d7b88c
Autor:
Kazuto Oya, Kenji Sakuma, Satoru Esumi, Yasuhiko Hashimoto, Masakazu Hatano, Yuki Matsuda, Yuki Matsui, Nobumi Miyake, Ikuo Nomura, Makoto Okuya, Nakao Iwata, Masaki Kato, Ryota Hashimoto, Kazuo Mishima, Norio Watanabe, Taro Kishi
Publikováno v:
Neuropsychopharmacology Reports, Vol 39, Iss 3, Pp 241-246 (2019)
Abstract Aim Whether patients with adult bipolar disorder (BD) who have been clinically stabilized with lithium or lamotrigine should continue this medication is not established fully. This systematic review and meta‐analysis evaluated the efficacy
Externí odkaz:
https://doaj.org/article/a799a5366f114eccb70be2319b3a810c
Autor:
Yusuke Kono, Iichiro Kawahara, Kohei Shinozaki, Ikuo Nomura, Honoka Marutani, Akira Yamamoto, Takuya Fujita
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 388 (2021)
For developing oral drugs, it is necessary to predict the oral absorption of new chemical entities accurately. However, it is difficult because of the involvement of efflux transporters, including P-glycoprotein (P-gp), in their absorption process. I
Externí odkaz:
https://doaj.org/article/080201cf63014f8e9324f5c73e7659e5
Publikováno v:
Vascular Health and Risk Management, Vol 2009, Iss default, Pp 315-320 (2009)
Ikuo Nomura1, Johji Kato2, Kazuo Kitamura11Department of Internal Medicine, Circulatory and Body Fluid Regulation, Faculty of Medicine; 2Frontier Science Research Center, University of Miyazaki, Kiyotake, Miyazaki, JapanAbstract: Chronic kidney disea
Externí odkaz:
https://doaj.org/article/5ec49c8f27c347589d5c4abf69fb9e10
Autor:
Kenji Sakuma, Taro Kishi, Shohei Sanji, Ikuo Nomura, Masakazu Hatano, Makoto Okuya, Nakao Iwata
Publikováno v:
Psychiatry and Clinical Neurosciences. 77:297-299
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b8afe7cbdd6d03e9e7aeab508fff883
https://doi.org/10.1111/pcn.13537
https://doi.org/10.1111/pcn.13537
Autor:
Yuki Matsuda, Kenji Sakuma, Masakazu Hatano, Makoto Okuya, Nakao Iwata, Taro Kishi, Ikuo Nomura, Toshikazu Ikuta
Publikováno v:
Molecular Psychiatry. 27:1136-1144
A systematic review and random-effects model network meta-analysis was conducted to compare the efficacy, acceptability, tolerability, and safety of pharmacological interventions for adults with acute bipolar mania. We searched PubMed, the Cochrane L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::638f27e66ca698f2a5aa094075476638
https://doi.org/10.1038/s41380-021-01334-4
https://doi.org/10.1038/s41380-021-01334-4
Autor:
Margaret Moline, Makoto Okuya, Takehiro Taninaga, Nakao Iwata, Kenzo Muramoto, Michinori Koebis, Ikuo Nomura, Maika Nishida, Taro Kishi, Naoki Kubota, Kenji Sakuma
Publikováno v:
Neuropsychopharmacology Reports
Most conventional insomnia medications are gamma‐aminobutylic acid receptor agonists. However, physical dependence is a concern and one of the major limiting factors for long‐term treatment. The dual orexin receptor antagonists, suvorexant and le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c19e5bc56db988660805f4504e7c3a7d
http://europepmc.org/articles/PMC8698673
http://europepmc.org/articles/PMC8698673
Autor:
Kohei Ninomiya, Shinji Matsunaga, Makoto Okuya, Yuji Okuyama, Nakao Iwata, Ikuo Nomura, Kenji Sakuma, Momoko Kubo, Yuki Matsui, Kazuto Oya, Taro Kishi
Publikováno v:
Neuropsychopharmacology Reports
Aim There have been no previous reports on the efficacy and safety of suvorexant for insomnia in people with psychiatric disorders. Methods This one‐week, prospective, single‐arm, clinical trial of fixed dose of suvorexant (20 mg if ages 18–64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c294f2c3c9c4f29d4b1fcb2cc7277ffd
https://doi.org/10.1002/npr2.12069
https://doi.org/10.1002/npr2.12069
Publikováno v:
Neuropsychiatric Disease and Treatment. 15:1479-1486
Objective: This study was a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials, investigating the efficacy and tolerability/safety of melatonin receptor agonists, such as ramelteon and melatonin, for patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9fb5615c162aba27c7e85e446ab9df9
https://doi.org/10.2147/ndt.s198899
https://doi.org/10.2147/ndt.s198899